Quethera Ltd

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. The initial focus is on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. Quethera is working alongside world leaders in the glaucoma field to design clinical trials capable of examining the efficacy and safety of novel therapies in patients who lose parts of their visual field at an accelerated rate (fast-progressors). The company has expertise in gene therapeutic design and development sufficient to progress its pipeline through preclinical testing and into clinical development.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

Neuroprotective Therapy Company Quethera Reveals Gene Therapy Results at ARVO

  Quethera, a biopharmaceutical company developing therapies for ocular disorders, today presented strong efficacy data…

read more

Gene Therapy Company Quethera Obtains Grant From Wellcome Trust Pathfinder Award Scheme

Quethera Ltd, a privately funded gene therapy company based at the Babraham Research Campus in…

read more

Quethera Announces Seed Financing To Develop Gene Therapy Aimed At Preventing Blindness In Glaucoma Patients

Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has…

read more

Quethera will present pre-clinical efficacy data at the Association for...

Quethera will present pre-clinical efficacy data at the Association for Research in Vision and...

read more

More Companies in Medical / Biotechnology